Transdermal Delivery Solutions Corporation (TDSC), www.TDSC.us, announced today entering a pivotal phase of clinical trials. The British National Health Service (NHS) Ethics filings (IRAS) preliminary to the Medicine and Health Products Review Authority’s (MHRA) approval of Clinical Trial Applications (CTA) for TDSC’s Investigational Medical Product Dossier on Hormone Replacement Technologies’ Testagen® HypoSpray® were filed on November 25th and 30th, 2015. NHS Ethics will review the protocols together on December 16th, 2015.
Palm Beach County‘s life science industry — controversial for the amount of tax dollars sunk into it more than a decade ago — will be put under a microscope for potential expansion.
Business Development Board president Kelly Smallridge on Tuesday unveiled an effort aimed at expanding the county’s life science businesses.
The economic development group is “going back to the table to inventory the county’s life science assets,” Smallridge said.
A $55,000 study by Maryland-based Facility Logix will help the Business Development Board understand the assets of the life science sector and identify gaps to better market the county, she said.
The county’s biotech sector includes Scripps Florida and the Max Planck Florida Institute for Neuroscience in Jupiter, about 200 biotech companies, hospitals, and educational programs including Scripps, Max Planck and Florida Atlantic University’s School of Medicine.
Now that Florida’s economy has essentially recovered from the recession, Smallridge said it’s time for economic officials to make a bigger play for science-related businesses as well as figure how to keep spin-off companies from the institutes in the area.